Metabolic · Metabolic peptide (research)
SLU-PP-332
- Drug class
- Metabolic peptide (research)
- Status
- Compounded (503A)
- Also known as
- slu pp 332, slupp332, err agonist, exercise mimetic
- Reviewed
- 2026-06-01 · Dr. Ana Lisa Carr, MD
What SLU-PP-332 is studied for
- Exercise mimetic (research)
- Mitochondrial biogenesis (research)
- Endurance research (research)
Mechanism of action
SLU-PP-332 is being studied in the metabolic category. ERR agonist studied as an exercise mimetic for endurance and metabolism. Mechanism of action varies by study model; refer to the kindr clinical library for a deeper writeup.
Frequently asked questions
What is SLU-PP-332?
SLU-PP-332 is a metabolic peptide. ERR agonist studied as an exercise mimetic for endurance and metabolism.
What is SLU-PP-332 studied for?
Published research has examined SLU-PP-332 for exercise mimetic, mitochondrial biogenesis, endurance research. Human clinical evidence varies by indication.
Is SLU-PP-332 FDA-approved?
No. SLU-PP-332 is not FDA-approved for the indications listed. It is available compounded by 503A pharmacies under clinician supervision, or for international research use only on this catalog.
How is SLU-PP-332 used in research?
Protocols vary by study. SLU-PP-332 is typically administered subcutaneously in research settings. No validated human therapeutic dose exists outside FDA-approved indications.
What are the known risks?
Long-term human safety data for SLU-PP-332 is limited. Theoretical risks vary by mechanism. Any human use should be supervised by a licensed clinician.